Frontiers in Oral Health (Mar 2022)

Retraction: Tumor Microenvironment in Oral Cancer Following Neoadjuvant Pembrolizumab: Preliminary Analysis of the Histopathologic Findings

  • Frontiers Editorial Office

DOI
https://doi.org/10.3389/froh.2022.893486
Journal volume & issue
Vol. 3

Abstract

Read online

No abstracts available.